Literature DB >> 11575869

Orofacial effects of antiretroviral therapies.

C Scully1, P Diz Dios.   

Abstract

This paper summarises some of the oral adverse effects of antiretroviral agents. Some are related to bone marrow suppression which may also predispose to mouth ulcers. Erythema multiforme and toxic epidermal necrolysis are especially well recognized in HIV disease, particularly as reactions to sulphonamides and to antiretroviral agents. Oral lichenoid reactions have been described in HIV disease often relating to zidovudine use. Didanosine has also produced erythema multiforme and not unusually induces xerostomia, again by an unknown mechanism. Xerostomia may be seen in up to one-third of patients taking didanosine. Taste abnormalities are common with the protease inhibitors and oral and perioral paraesthesia can be a disturbing adverse effect. Ritonavir in particular can give rise to circumoral paraesthesia in over 25% of patients. Indinavir can also produce cheilitis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11575869

Source DB:  PubMed          Journal:  Oral Dis        ISSN: 1354-523X            Impact factor:   3.511


  23 in total

1.  The HIV protease inhibitor lopinavir/ritonavir (Kaletra) alters the growth, differentiation and proliferation of primary gingival epithelium.

Authors:  M Israr; D Mitchell; S Alam; D Dinello; J J Kishel; C Meyers
Journal:  HIV Med       Date:  2010-08-15       Impact factor: 3.180

2.  Effect of the HIV nucleoside reverse transcriptase inhibitor zidovudine on the growth and differentiation of primary gingival epithelium.

Authors:  D Mitchell; M Israr; S Alam; J Kishel; D Dinello; C Meyers
Journal:  HIV Med       Date:  2012-01-26       Impact factor: 3.180

Review 3.  Indinavir-induced retinoid-like effects: incidence, clinical features and management.

Authors:  Jesús García-Silva; Manuel Almagro; Carmen Peña-Penabad; Eduardo Fonseca
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

4.  Effect of the HIV protease inhibitor amprenavir on the growth and differentiation of primary gingival epithelium.

Authors:  Mohd Israr; Danielle Mitchell; Samina Alam; Donald Dinello; Joseph J Kishel; Craig Meyers
Journal:  Antivir Ther       Date:  2010

5.  Effects of long-term use of HAART on oral health status of HIV-infected subjects.

Authors:  Wipawee Nittayananta; Sineepat Talungchit; Sutep Jaruratanasirikul; Kachornsakdi Silpapojakul; Panthip Chayakul; Ampaipith Nilmanat; Nannapat Pruphetkaew
Journal:  J Oral Pathol Med       Date:  2010-02-22       Impact factor: 4.253

6.  HIV nucleoside reverse transcriptase inhibitors efavirenz and tenofovir change the growth and differentiation of primary gingival epithelium.

Authors:  D Mitchell; M Israr; S Alam; D Dinello; J Kishel; R Jia; C Meyers
Journal:  HIV Med       Date:  2013-10-31       Impact factor: 3.180

7.  Antiretroviral Drug-Associated Oral Lichenoid Reaction in HIV Patient: A Case Report.

Authors:  Pratanporn Arirachakaran; Mattana Hanvanich; Piyanad Kuysakorn; Kobkan Thongprasom
Journal:  Int J Dent       Date:  2010-07-05

8.  Effect of HAART on salivary gland function in the Women's Interagency HIV Study (WIHS).

Authors:  M Navazesh; R Mulligan; R Karim; W J Mack; S Ram; H Seirawan; J Greenspan; D Greenspan; J Phelan; M Alves
Journal:  Oral Dis       Date:  2008-11-11       Impact factor: 3.511

9.  HIV protease inhibitors block oral epithelial cell DNA synthesis.

Authors:  Robert J Danaher; Chunmei Wang; Andrew T Roland; Charlotte S Kaetzel; Richard N Greenberg; Craig S Miller
Journal:  Arch Oral Biol       Date:  2009-12-24       Impact factor: 2.633

Review 10.  Oral complications of HIV disease.

Authors:  Jair C Leao; Camila M B Ribeiro; Alessandra A T Carvalho; Cristina Frezzini; Stephen Porter
Journal:  Clinics (Sao Paulo)       Date:  2009-05       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.